Search

everythinglearnresearchcommunity

for

Search:↓

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

AKR1C enzymes in scalp glands decrease with age, possibly affecting hair loss.

Age-related changes in scalp glands may affect hair health, but sulforaphane might help.

As people age, certain enzymes in scalp glands decrease, affecting hair health.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

DA-9401 helps protect rat testis from finasteride damage.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.